Latest disclosed round
Series B
- Date
- 2025-09-01
- Amount
- USD 80m
- Sector
- Biotech & techbio
- Companies House
- 13641471
Series B
Charm Therapeutics
AI drug discovery (structure-based, oncology)
CandidateSeries BLondon
Evidence status
Review retained
- Identity
- Candidate
- Match
- High candidate
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
6 linked investors
Funding record
1 disclosed round
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2025-09-01 | Series B | $80M / €68.5M | New Enterprise Associates (NEA), SR One, OrbiMed, F-Prime, Khosla Ventures, NVIDIA |
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.